What services does JCC Group provide for pharmaceutical and biologics manufacturers?

JCC Group offers end-to-end regulatory consulting services for pharmaceutical and biologics companies, including 21 CFR Part 211 cGMP compliance, Quality Management System (QMS) design, validation strategy, FDA inspection readiness, supplier qualification, data integrity assessments, and harmonization with ICH international standards (Q7, Q8, Q9, Q10, and Q11). Our consultants partner with clients across the full product lifecycle — from facility start-up and clinical-stage manufacturing through commercial production and post-approval changes.

What types of companies does JCC Group work with?

We support a broad spectrum of clients, including emerging biotech startups, contract manufacturers (CMOs/CDMOs), mid-size pharmaceutical companies, global drug manufacturers, biologics and cell & gene therapy developers, and international manufacturers exporting to the U.S. market. Whether you are launching your first product or managing a multi-site global operation, our services scale to fit your needs.

What is 21 CFR Part 211, and who must comply?

21 CFR Part 211 establishes the FDA's Current Good Manufacturing Practice (cGMP) requirements for finished pharmaceuticals. It applies to any company involved in manufacturing, processing, packaging, labeling, or holding human and veterinary drug products distributed in the United States — including drug substance and drug product manufacturers, contract facilities, and repackagers.

How does JCC Group help companies achieve 21 CFR Part 211 compliance?

We provide comprehensive support including cGMP gap assessments, QMS design and implementation, SOP and documentation development, equipment qualification (IQ/OQ/PQ), process and cleaning validation, quality control laboratory compliance, change control programs, CAPA systems, and mock FDA inspections. Our team builds compliance programs tailored to your operations — not generic templates.

Does JCC Group support biologics manufacturers under 21 CFR Part 211?

Yes. While biologics are also governed by 21 CFR Part 600-series regulations, Part 211 still applies to many aspects of biologic drug product manufacturing. We support biologics manufacturers across monoclonal antibodies, recombinant proteins, vaccines, cell and gene therapies, and biosimilars — addressing both small-molecule and large-molecule complexities.

What are ICH guidelines, and why do they matter?

The International Council for Harmonisation (ICH) develops globally recognized standards for pharmaceutical quality, safety, and efficacy. Compliance with ICH guidelines — especially Q7 (API GMP), Q8 (Pharmaceutical Development), Q9 (Quality Risk Management), Q10 (Pharmaceutical Quality System), and Q11 (Drug Substance Development) — is essential for companies seeking global market access and harmonized regulatory approval across the U.S., EU, Japan, and other ICH regions.

How does JCC Group help companies align with ICH standards?

Our consultants integrate ICH principles into every aspect of our consulting work. We design Pharmaceutical Quality Systems aligned with ICH Q10, implement quality risk management frameworks per ICH Q9, support development activities under Q8/Q11, and ensure API manufacturing aligns with ICH Q7 — enabling clients to meet both FDA expectations and global harmonized requirements simultaneously.

Can JCC Group build a Quality Management System (QMS) from scratch?

Absolutely. We design and implement complete Quality Management Systems for new facilities, startups, and companies transitioning from clinical-stage to commercial manufacturing. Our QMS deliverables include Quality Manuals, SOPs, work instructions, forms, Master Production Records, Batch Production Records, change control systems, and integrated documentation control platforms.

Does JCC Group provide ongoing QMS maintenance and support?

Yes. Beyond initial implementation, we offer long-term advisory services to keep your QMS current with evolving regulations, support periodic management reviews, conduct internal audits, manage CAPA effectiveness checks, and provide regulatory intelligence updates. Many clients engage us as their long-term regulatory partner rather than a one-time consultant.

What happens during a mock FDA inspection conducted by JCC Group?

Our mock inspections replicate real FDA methodology — including facility walkthroughs, document reviews, employee interviews, and front-room/back-room dynamics. We assess your operations against 21 CFR Part 211, your QMS, and applicable ICH standards, then deliver a detailed report with prioritized findings, root cause insights, and clear remediation recommendations.

Can JCC Group help if we received a Form 483 or FDA Warning Letter?

Yes — rapid-response remediation is one of our core specialties. Our team conducts immediate root cause investigations, develops comprehensive CAPA plans, drafts written responses that meet FDA expectations, and manages the remediation process from start to finish. We have helped clients successfully close significant findings and restore compliance under tight deadlines.

Compliance Expertise

JJCC Group Compliance & Regulatory Experts

JJCC Group delivers expert regulatory and compliance solutions, helping businesses navigate complex regulations, minimize risk, and bring high-quality products to market efficiently.

Delivering tailored compliance strategies and expert guidance to simplify regulations

Message from the founder

At JJCC Group, we believe that regulatory strategy is not simply about compliance—it is about building a foundation for innovation, product quality, and long-term market success.

Over the past decade, industries regulated by the U.S. Food and Drug Administration have undergone significant transformation. Regulatory expectations are evolving rapidly, scientific standards are becoming more rigorous, and global markets are demanding higher levels of transparency and product safety. In this environment, companies must move beyond a reactive approach to regulation and instead integrate regulatory science into the core of their product development strategy.

JJCC Group was founded with a clear vision: to provide companies with the scientific insight, regulatory expertise, and strategic guidance necessary to successfully navigate complex regulatory landscapes. Our work supports organizations operating in highly regulated sectors, including food and dietary ingredients, medical devices, pharmaceuticals, and tobacco and nicotine products. Through rigorous scientific evaluation, thoughtful regulatory planning, and proactive engagement with regulatory frameworks, we help our clients transform compliance challenges into strategic opportunities.

At the heart of our philosophy is a commitment to scientific integrity and practical solutions. Regulatory success requires more than submitting documents—it requires understanding the science behind the regulations, anticipating regulatory expectations, and designing products and processes that meet those expectations from the very beginning.

As the regulatory environment continues to evolve, JJCC Group remains committed to helping innovators bring safe, compliant, and high-quality products to market while strengthening the trust between industry, regulators, and consumers.

Mike Khalil –Founder, JJCC Group

Expert Industry Insight

Disciplinary Team

Operational Excellence

Learn More

“Driven by a results-oriented approach and an unwavering commitment to client success, Mike Khalil continues to empower businesses to stay compliant, “

Mike Khalil

Sr. Principal Consultant

Who We Are

President and Senior Consultant

Mike Khalil is a seasoned entrepreneur and respected industry leader with over 35 years of experience driving success across the pharmaceutical, medical device, nutrition supplement, food & beverage, and tobacco sectors. With a passion for helping ambitious businesses thrive, Mike has led dozens of successful ventures, building a reputation for strategic leadership and regulatory excellence.

Our Vision

To simplify regulatory compliance and empower businesses to thrive in highly regulated industries.

Our Mission

Empower companies with innovative, practical, and expert compliance solutions—transforming complex

Decades of Expertise

Where Science Meets Strategy

JJCC combines decades of experience, a multi-disciplinary team, and innovative strategies to help businesses navigate complex regulations, optimize operations, and bring high-quality products to market efficiently.

Compliance Strategy

Transform regulatory challenges into opportunities with innovative, forward-thinking solutions

Scientific Precision

Our team of experts brings unmatched knowledge in toxicology, research, and regulatory science to every project.

Accelerated Market

We streamline operations and compliance processes, helping your products reach the market faster and smarter.

Expertise You Can Trust

A Dedicated Talented team Committed to Excellence!

For over 30 years, J&J Compliance Consulting Group (JJCC Group) has been teaming up with prominent brands and businesses from around the world to optimize their operations, guiding enterprises with industry-specific products through regulatory compliance, ensuring efficient speed to market. Offering unmatched expertise and insight in an overly complex field,

30+

Years Of Experience

Our firm thrives on simplifying the process by providing efficient strategies to accelerate and streamline your compliance and enhanced quality standards that minimize regulatory risks while expediting launch.

Our Partner

Partner with the Best To Ensure Your Company’s Success

Join forces with JJCC’s expert team to navigate regulations, streamline processes, and achieve successful product launches with confidence.

Our Team

The team behind JJCC group

Our team of scientists, regulatory specialists, quality experts, and technical writers brings unmatched experience and dedication to guide your products safely and efficiently to market.

Dr. Rakesh Gurdu Ph.D.

Lead Toxicologist

Dr. William McGill Ph.D.

Health and Behavioral Science

Dr. Morgana Moretti Ph.D.

Researcher and Medical Writer

Paula Guimarães RN, Ph.D.

Lead Toxicologist

Bill Nguyen

Engineer and Scientist

Victoria Cole

Project Manager

Get Started today

Strategic Simplicity. Powerful Results.

Partner with our expert team to ensure regulatory compliance, streamline your processes, and bring your products to market with confidence.

Testimonials

What our client say about us

Hear from our clients how JJCC’s expert regulatory and scientific support has helped them achieve compliance, streamline processes, and successfully bring their products to market.

JJCC guided us through our first FDA approval seamlessly. Their expertise made the entire process smooth and stress-free.

Eric Thompson CEO

The team’s regulatory and scientific support was invaluable. JJCC ensured our products met all compliance standards efficiently.

Mark Rivera Product Manager

JJCC’s expert guidance helped us streamline operations and maintain top-quality standards across our product line.

Emily Chen Director of Quality

From regulatory submissions to manufacturing support, JJCC has been a trusted partner at every stage of our growth.

David Lorenzo Founder